Hexcel (HXL) Q4 2025 Earnings Call Transcript

Hexcel reported 2025 sales of $1.894 billion, adjusted EPS of $1.76, and free cash flow of $157 million, then guided to 2026 sales of $2.0 billion-$2.1 billion, EPS of $2.10-$2.30, and free cash flow above $195 million. Management said commercial aerospace sales should grow low to mid-double digits in 2026, with A350 production assumed at 80 units, while FX remains a headwind and leverage is temporarily elevated at 2.7x due to the $350 million ASR. The quarterly dividend was raised 6% to $0.18 per share, and management expects incremental margins in the low-to-mid 30% range as production ramps.

Analysis

HXL’s setup is less about this quarter’s margin print and more about the shape of the next 6-12 months: the company is effectively pre-investing into a volume inflection before the OEMs fully show it in reported builds. That creates a near-term earnings asymmetry where the stock can de-rate on any hiccup in A350/737/787 cadence, but once rate confidence hardens, the fixed-cost absorption torque should show up quickly because most of the incremental profit is being deferred, not destroyed.

The most important second-order effect is on the supply chain itself. By bringing idled composite capacity back online ahead of demand, HXL is signaling that the bottleneck is now less about materials availability and more about labor readiness, qualification, and line reactivation timing; that favors the largest, best-capitalized aerospace suppliers and pressures smaller niche composite names that lack balance-sheet flexibility. Airbus and Boeing also benefit indirectly: HXL’s willingness to carry early capacity reduces the risk of another supplier-induced rate miss, which should lower perceived execution risk across the narrow-body and wide-body recovery complex.

The market may be underestimating how much of 2026 is already “owned” by FX and working-capital noise. If FX is a persistent headwind and cash conversion remains lumpy, headline EPS beats may not translate into multiple expansion until leverage is back below 2x and repurchase capacity reopens. Conversely, if build-rate data keeps improving, the business has a credible path to a re-rating because operating leverage can outpace revenue growth for several quarters once utilization crosses the threshold.

Contrarian take: the bullish consensus is probably too linear on the OEM ramp. The bigger risk isn’t a demand collapse; it’s a sequencing problem where customer pull improves but is offset by another 1-2 quarter delay in actual production normalization, leaving HXL with higher inventory, more hiring, and little near-term cash benefit. That is why this is a better trade on evidence of sustained production prints than on the earnings call alone.

Key Decisions for Investors

• Long HXL on a 3-6 month horizon, but size modestly until monthly Airbus/Boeing production data confirms the ramp; upside is a re-rating if leverage falls back under 2x and guidance proves conservative, downside is muted if the rate ramp slips but doesn’t break.
• Buy HXL calls 4-8 months out rather than stock if you want convexity to a production inflection; the key catalyst is not Q1 numbers but a few months of uninterrupted build-rate stability, which could compress implied volatility on a sustained beat path.
• Pair trade: long HXL / short a weaker aerospace supplier with higher leverage and less pricing power over the next 6-12 months; HXL has better balance-sheet repair optionality and more visible operating leverage when utilization improves.
• If already long, hedge near-term FX and working-capital noise with a partial profit-taking rule on any post-earnings strength until the company demonstrates two consecutive quarters of cash conversion above 100% and net leverage trending below 2.5x.
• Avoid chasing defense-only composites as the primary trade; HXL’s cleaner catalyst is commercial aerospace rate recovery, while defense is a slower, steadier offset rather than the main earnings driver in 2026.